FWP
NASDAQ:FWP
Forward Pharma A/S
- Stock
Last Close
1.95
27/12 21:00
Volume Today
43.35K
Avg: 9.84K
PE Ratio
151.31
PFCF: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||
average payables | 1.38M - | 2.82M 105.01% | 3.03M 7.35% | 1.64M 45.93% | 815.50K 50.21% | 255K 68.73% | 279K 9.41% | 273K 2.15% | |
average receivables | 766K - | 973.50K 27.09% | 637K 34.57% | 681K 6.91% | 691.50K 1.54% | 360.50K 47.87% | 280K 22.33% | 213.50K 23.75% | |
book value per share | 45.14 - | 26.46 41.38% | 23.20 12.32% | 3.30 85.76% | 12.16 268.10% | 11.42 6.05% | 11.47 0.41% | 10.14 11.61% | |
capex per share | -0.00 - | -0.06 4,597.13% | -0.00 91.93% | -0.00 97.61% | |||||
capex to depreciation | -2 - | -10.32 416.22% | -0.28 97.25% | -0.01 95.35% | |||||
capex to operating cash flow | 0.00 - | 0.01 1,614.60% | 0.00 91.64% | -0.00 100.35% | |||||
capex to revenue | -0.00 - | ||||||||
cash per share | 18.59 - | 14.06 24.35% | 20.66 46.90% | 4.03 80.47% | 12.21 202.53% | 11.43 6.39% | 11.53 0.94% | 10.13 12.14% | |
days of inventory on hand | |||||||||
days payables outstanding | 17.56 - | ||||||||
days sales outstanding | 0.27 - | ||||||||
debt to assets | 0.01 - | 0.03 162.47% | 0.04 32.51% | 0.19 326.98% | 0.01 93.02% | 0.01 43.17% | 0.01 76.04% | 0.01 36.57% | |
debt to equity | 0.01 - | 0.04 168.18% | 0.05 34.04% | 0.24 404.75% | 0.01 94.28% | 0.01 43.50% | 0.01 77.08% | 0.01 36.88% | |
dividend yield | 1.56 - | ||||||||
earnings yield | -0.03 - | -0.04 57.39% | -0.05 13.47% | 1.31 2,873.68% | -0.24 118.02% | -0.10 59.43% | -0.13 39.58% | -0.05 66.08% | |
enterprise value | 673.08M - | 835.96M 24.20% | 647.30M 22.57% | 589.89M 8.87% | -45.62M 107.73% | -33.56M 26.44% | -30.88M 7.97% | -29.08M 5.84% | |
enterprise value over ebitda | -35.71 - | -22.41 37.25% | -11.89 46.93% | 0.50 104.19% | 5.11 926.93% | 7.95 55.52% | 4.79 39.78% | 15.37 220.95% | |
ev to operating cash flow | -71.15 - | -23.80 66.55% | -18.98 20.25% | 0.63 103.31% | 3.09 391.60% | 15.04 387.55% | 5.41 64.06% | 12.33 128.04% | |
ev to sales | 0.47 - | ||||||||
free cash flow per share | -1.92 - | -5.32 176.75% | -5.08 4.41% | 34.62 781.09% | -2.19 106.32% | -0.33 84.98% | -0.83 153.61% | -0.34 59.46% | |
free cash flow yield | -0.01 - | -0.04 203.41% | -0.05 21.09% | 1.34 2,876.16% | -0.40 129.80% | -0.05 87.35% | -0.12 133.95% | -0.06 52.26% | |
graham net net | 18.16 - | 13.23 27.18% | 19.61 48.26% | 3.28 83.30% | 12.09 269.17% | 11.37 5.97% | 11.41 0.35% | 10.06 11.81% | |
graham number | 62.61 - | 57.43 8.27% | 50.90 11.37% | 50.10 1.57% | 18.78 62.51% | 12.64 32.71% | 15.58 23.26% | 7.86 49.54% | |
income quality | 0.50 - | 0.95 90.82% | 1.02 7.77% | 1.02 0.18% | 1.70 65.41% | 0.53 68.82% | 0.89 67.61% | 1.25 40.75% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -47.36 - | ||||||||
interest debt per share | 0.08 - | ||||||||
inventory turnover | |||||||||
invested capital | |||||||||
market cap | 718.43M - | 888.23M 23.64% | 705.19M 20.61% | 699.44M 0.82% | 36.92M 94.72% | 44.04M 19.28% | 48.20M 9.46% | 41.69M 13.51% | |
net current asset value | 90.48M - | 93.59M 3.44% | 132.47M 41.54% | 89.66M 32.31% | 82.21M 8.31% | 77.57M 5.65% | 78.64M 1.38% | 70.79M 9.98% | |
net debt to ebitda | 2.41 - | 1.40 41.77% | 1.06 24.09% | -0.09 108.69% | 9.25 10,104.57% | 18.39 98.76% | 12.26 33.31% | 37.40 205.01% | |
net income per share | -3.86 - | -5.54 43.57% | -4.96 10.42% | 33.78 780.48% | -1.29 103.82% | -0.62 51.81% | -0.94 51.31% | -0.27 71.19% | |
operating cash flow per share | -1.92 - | -5.26 173.95% | -5.08 3.45% | 34.62 781.71% | -2.19 106.32% | -0.33 84.98% | -0.83 153.61% | -0.34 59.46% | |
payables turnover | 20.78 - | ||||||||
receivables turnover | 1.34K - | ||||||||
research and ddevelopement to revenue | 0.02 - | ||||||||
return on tangible assets | -0.08 - | -0.20 139.71% | -0.20 1.00% | 8.26 4,143.10% | -0.10 101.27% | -0.05 48.41% | -0.08 49.81% | -0.03 67.25% | |
revenue per share | 46.04 - | ||||||||
roe | -0.09 - | -0.21 144.93% | -0.21 2.17% | 10.23 4,879.44% | -0.11 101.04% | -0.05 48.71% | -0.08 50.70% | -0.03 67.41% | |
roic | -0.15 - | -0.66 351.65% | -0.75 13.30% | -8.41 1,023.86% | 0.15 101.74% | 0.07 53.09% | 0.04 37.39% | 0.06 28.64% | |
sales general and administrative to revenue | 0.01 - | ||||||||
shareholders equity per share | 45.14 - | 26.46 41.38% | 23.20 12.32% | 3.30 85.76% | 12.16 268.10% | 11.42 6.05% | 11.47 0.41% | 10.14 11.61% | |
stock based compensation to revenue | 0.01 - | ||||||||
tangible asset value | 222.39M - | 176.69M 20.55% | 155.80M 11.82% | 89.68M 42.44% | 82.21M 8.33% | 77.57M 5.65% | 78.64M 1.39% | 70.80M 9.98% | |
tangible book value per share | 45.14 - | 26.46 41.38% | 23.20 12.32% | 3.30 85.76% | 12.16 268.10% | 11.42 6.05% | 11.47 0.41% | 10.14 11.61% | |
working capital | 90.48M - | 93.59M 3.44% | 132.47M 41.54% | 89.71M 32.28% | 82.21M 8.35% | 77.57M 5.65% | 78.64M 1.38% | 70.79M 9.98% |
All numbers in USD (except ratios and percentages)